This federal contract award is a delivery order valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 3, 2025 and is a firm fixed-price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation is mentioned for this particular award.
Generated 3/12/25, 9:53 AM